E3 ligase FLRF (Rnf41) regulates differentiation of hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors

Experimental Hematology

Volumn 36, Issue 9, 2008, Pages 1110-1120

  Jing, Xin ^a   Infante, Jorge ^a   Nachtman, Ronald G ^a   Jurecic, Roland ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN; FLRF PROTEIN; GENE PRODUCT; INTERLEUKIN 3; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RNF41 PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL LINEAGE; COLONY FORMING CELL; DOWN REGULATION; ERYTHROID CELL; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOPRECIPITATION; LIGAND BINDING; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STEADY STATE; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; CELL LINE; CELL LINEAGE; COLONY-FORMING UNITS ASSAY; DOWN-REGULATION; ERYTHROPOIETIN; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; LIGANDS; MICE; PROTEIN BINDING; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, INTERLEUKIN-3; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; TRETINOIN;

MURINAE;

EID: 49349109951     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.04.001     Document Type: Article

References (56)

1. Metcalf D. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc Natl Acad Sci U S A 88 (1991) 11310-11314
2. Smithgall T.E. Signal transduction pathways regulating hematopoietic differentiation. Pharmacol Rev 50 (1998) 1-19
3. Thomas D., Vadas M., and Lopez A. Regulation of haematopoiesis by growth factors-emerging insights and therapies. Expert Opin Biol Ther 4 (2004) 869-879
4. Barreda D.R., Hanington P.C., and Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 28 (2004) 509-554
5. Richmond T.D., Chohan M., and Barber D.L. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 15 (2005) 146-155
6. Yasukawa H., Sasaki A., and Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18 (2000) 143-164
7. Jackson P.K., Eldridge A.G., Freed E., et al. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol 10 (2000) 429-439
8. Joazeiro C.A., and Weissman A.M. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102 (2000) 549-552
9. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem 70 (2000) 503-533
10. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 3 (2002) 20-26
11. Sakamoto K.M. Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Mol Genet Metab 77 (2002) 44-56
12. Pagano M., and Benmaamar R. When protein destruction runs amok, malignancy is on the loose. Cancer Cell 4 (2003) 251-256
13. Thien C.B., and Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2 (2001) 294-307
14. Fang D., Wang H.Y., Fang N., Altman Y., Elly C., and Liu Y.C. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3- kinase for ubiquitination in T cells. J Biol Chem 276 (2001) 4872-4878
15. Fang D., and Liu Y.C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2 (2001) 870-875
16. Fujimoto M., and Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 24 (2003) 659-666
17. Kubo M., Hanada T., and Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 4 (2003) 1169-1176
18. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22 (2004) 503-529
19. Abdullah J.M., Li X., Nachtman R.G., and Jurecic R. FLRF, a novel evolutionarily conserved RING finger gene, differentially expressed in mouse fetal and adult hematopoietic stem cells and progenitors. Blood Cells Mol Dis 27 (2001) 320-333
20. Diamonti A.J., Guy P.M., Ivanof C., Wong K., Sweeney C., and Carraway III K.L. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc Natl Acad Sci U S A 99 (2002) 2866-2871
21. Qiu X.B., and Goldberg A.L. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc Natl Acad Sci U S A 99 (2002) 14843-14848
22. Qiu X.B., Markant S.L., Yuan J., and Goldberg A.L. Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. EMBO J 23 (2004) 800-810
23. Zhong L., Tan Y., Zhou A., Yu Q., and Zhou J. RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity. J Biol Chem 280 (2005) 9425-9430
24. Tsai S., Bartelmez S., Sitnicka E., and Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8 (1994) 2831-2841
25. Zayas J., Spassov D.S., Nachtman R.G., and Jurecic R. Hematopoietic stem cells and multipotent progenitors express new truncated intracellular form of c-kit receptor. Stem Cells Dev 17 (2008) 351-361
26. Christensen J.L., and Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A 98 (2001) 14541-14546
27. Terskikh A.V., Miyamoto T., Chang C., Diatchenko L., and Weissman I.L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102 (2003) 94-101
28. Tsai S. Differential effects of c-fms and c-kit ligands on the lineage development of the lymphohematopoietic cell line EML C1. Cancer Chemother Pharmacol 38 suppl (1996) S58-S63
29. Lawson N.D., Krause D.S., and Berliner N. Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines. Exp Hematol 26 (1998) 1178-1185
30. Schmitt T.M., and Zuniga-Pflucker J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17 (2002) 749-756
31. Chiang M.Y., and Monroe J.G. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood 94 (1999) 3621-3632
32. Pawlak G., Grasset M.F., Arnaud S., Blanchet J.P., and Mouchiroud G. Receptor for macrophage colony-stimulating factor transduces a signal decreasing erythroid potential in the multipotent hematopoietic EML cell line. Exp Hematol 28 (2000) 1164-1173
33. Bourette R.P., De Sepulveda P., Arnaud S., Dubreuil P., Rottapel R., and Mouchiroud G. Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal. J Biol Chem 276 (2001) 22133-22139
34. Du Y., Campbell J.L., Nalbant D., et al. Mapping gene expression patterns during myeloid differentiation using the EML hematopoietic progenitor cell line. Exp Hematol 30 (2002) 649-658
35. Kirito K., Fox N., and Kaushansky K. Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 102 (2003) 3172-3178
36. Metcalf D. Clonal Culture of Hematopoietic Cells: Techniques and Applications (1984), Elsevier Press, New York
37. Heyworth C.M., and Spooncer E. In vitro clonal assays for murine multipotential and lineage restricted myeloid progenitor cells. In: Testa N.G., and Molineux G. (Eds). Haemopoiesis: A Practical Approach (1993), IRL Press, Oxford, UK 37-53
38. Chen C., and Sytkowski A.J. Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood 104 (2004) 73-80
39. Miyakawa Y., Rojnuckarin P., Habib T., and Kaushansky K. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem 276 (2000) 2494-2502
40. Collins S.J. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 16 (2002) 1896-1905
41. Klein E.S., Wang J.W., Khalifa B., Gavigan S.A., and Chandraratna R.A. Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions. J Biol Chem 275 (2000) 19401-19408
42. Zhu J., Gianni M., Kopf E., et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins. Proc Natl Acad Sci U S A 96 (1999) 14807-14812
43. Zandstra P.W., Lauffenburger D.A., and Eaves C.J. A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood 96 (2000) 1215-1222
44. Viswanathan S., Benatar T., Rose-John S., Lauffenburger D.A., and Zandstra P.W. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells 20 (2002) 119-138
45. Rubin C., Gur G., and Yarden Y. Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation. Cell Res 15 (2005) 66-71
46. Katz M., Shtiegman K., Tal-Or P., et al. Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic 3 (2002) 740-751
47. Liu J., Plotnikov A., Banerjee A., et al. Ligand-independent pathway that controls stability of interferon alpha receptor. Biochem Biophys Res Commun 367 (2008) 388-393
48. Cao Z., Wu X., Yen L., Sweeney C., and Carraway III K.L. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Mol Cell Biol 27 (2007) 2180-2188
49. Johnson B.S., Mueller L., Si J., and Collins S.J. The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation. Blood 99 (2002) 746-753
50. Jutong S., and Collins S.J. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood 100 (2003) 4401-4409
51. Ferrucci P.F., Grignani F., Pearson M., Fagioli M., Nicoletti I., and Pelicci P.G. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc Natl Acad Sci U S A 94 (1997) 10901-10906
52. Fanelli M., Minucci S., Gelmetti V., Nervi C., Gambacorti-Passerini C., and Pelicci P.G. Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood 93 (1999) 1477-1481
53. Fenaux P., Wang Z.Z., and Degos L. Treatment of acute promyelocytic leukemia by retinoids. Curr Top Microbiol Immunol 313 (2007) 101-128
54. Scaglioni P.P., and Pandolfi P.P. The theory of APL revisited. Curr Top Microbiol Immunol 313 (2007) 85-100
55. Alcalay M., Meani N., Gelmetti V., et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest 112 (2003) 1751-1761
56. Yen L., Cao Z., Wu X., et al. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res 66 (2006) 11279-11286